Cincinnati Academics Contribute To New Antiepileptic Drug Handbook
CINCINNATISix University of Cincinnati (UC) faculty members have coauthored a new handbook for physicians titled Clinicians Guide to Antiepileptic Drug Use.
According to Michael Privitera, MD, the handbook and PDA reference, published by Lippincott, Williams & Wilkins, is the first reference of its kind for the different specialties that use antiepileptic medications for seizure control and non-seizure indications like pain, headache and psychiatric disorders.
Designed as a quick point-of-care reference, it provides guidelines on use of antiepileptic drugs for treatment of seizures, psychiatric disorders, pain and headache.
The other UC authors are Jennifer Cavitt, MD, David Ficker, MD, and Jerzy Szaflarski, MD, PhD, all from the department of neurology and the Neuroscience Institute, Marcia Kaplan, MD, psychiatry, and visiting faculty member Timothy Welty, PharmD.
For more information call Chris Gates, call (513) 558-5440.
Tags
Related Stories
UC expert weighs in on current MASH treatment approaches
June 5, 2026
As MedCentral recently reported, pending broader pharmacologic approvals for metabolic dysfunction-associated steatohepatitis (MASH), lifestyle modifications remain the go-to intervention.
At least two weather patterns increase headaches, UC study suggests
June 4, 2026
University of Cincinnati physicians and collaborators identified two specific weather patterns that increase headache and migraine risk and found the preventive medication fremanezumab (Ajovy) can reduce weather‑associated headaches. The findings will be presented at the American Headache Society Annual Scientific Meeting in Orlando.
UC researcher secures $3.3M grant to study microplastics’ impact on heart
June 2, 2026
The National Institute of Environmental Health Sciences awarded a $3.3M grant to University of Cincinnati researcher Hong‑Sheng Wang, PhD, to study how microplastics and nanoplastics affect cardiovascular health.